India’s First PRP Guidelines Launched at ReGen 2025 Conference
Chennai: The second edition of ReGen 2025, a two-day international conference on regenerative medicine, orthobiologics, pain management, and sports injury rehabilitation, has commenced in Chennai. This landmark event has drawn over 500 healthcare professionals from India and abroad, highlighting the growing interest in regenerative medicine.
Launch of India’s First PRP Guidelines
A significant milestone was achieved with the launch of India’s first-ever Platelet-Rich Plasma (PRP) Guidelines. Developed by 17 leading experts, these guidelines provide a comprehensive, evidence-based framework for PRP therapy. Dr. G. K. Kumar emphasized the importance of standardized protocols in ensuring consistent practices and outcomes. The guidelines emphasize patient-centered care, informed consent, and long-term follow-up, setting a new benchmark for clinical excellence in regenerative practices.
Expert Insights
Dr. Sharmila Tulpule, Chairperson of ReGen 2025, highlighted the conference’s role in accelerating research, clinical adoption, and policy alignment in regenerative medicine. According to Dr. A Navaladishankar, the release of these PRP guidelines marks a turning point for India’s regenerative medicine ecosystem, providing a foundation for safe, standardized, and evidence-based care.
Conference Highlights
The conference featured a range of topics, including cutting-edge regenerative procedures and technologies such as autologous blood products, allogenic cell therapy, growth factor therapies, and bone marrow aspirate concentrate. These technologies are rapidly reshaping clinical protocols by offering minimally invasive, personalized solutions to chronic pain, sports injuries, and degenerative diseases.
A one-day hands-on workshop was conducted at the Tamil Nadu Government Multi Super Speciality Hospital, providing participants with direct exposure to imaging-guided regenerative treatment procedures and live demonstrations. The conference also included keynote lectures, research sessions, and an innovation showcase, designed to shape the future of biologic therapies in India.
